Regarding other clinical variables contemplated here, STC2 is an estrogen-responsive gene co-expressed with the estrogen receptor in breast cancer [45,46,47], but according to our results, we cannot rule out that the change in the expression of STC2 is linked with the gender of our patients. Here, STC2 is linked to breast cancer.